JP2008500997A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500997A5
JP2008500997A5 JP2007513939A JP2007513939A JP2008500997A5 JP 2008500997 A5 JP2008500997 A5 JP 2008500997A5 JP 2007513939 A JP2007513939 A JP 2007513939A JP 2007513939 A JP2007513939 A JP 2007513939A JP 2008500997 A5 JP2008500997 A5 JP 2008500997A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
alkoxycarbonyl
unsaturated
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007513939A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500997A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/052416 external-priority patent/WO2005118540A2/en
Publication of JP2008500997A publication Critical patent/JP2008500997A/ja
Publication of JP2008500997A5 publication Critical patent/JP2008500997A5/ja
Pending legal-status Critical Current

Links

JP2007513939A 2004-05-28 2005-05-27 アロマターゼ阻害剤としての二環式の窒素含有複素環 Pending JP2008500997A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH9152004 2004-05-28
PCT/EP2005/052416 WO2005118540A2 (en) 2004-05-28 2005-05-27 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors

Publications (2)

Publication Number Publication Date
JP2008500997A JP2008500997A (ja) 2008-01-17
JP2008500997A5 true JP2008500997A5 (enExample) 2008-07-10

Family

ID=34968588

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007513942A Expired - Fee Related JP5179174B2 (ja) 2004-05-28 2005-05-27 アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ[1,5−a]ピリジン誘導体
JP2007513939A Pending JP2008500997A (ja) 2004-05-28 2005-05-27 アロマターゼ阻害剤としての二環式の窒素含有複素環

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007513942A Expired - Fee Related JP5179174B2 (ja) 2004-05-28 2005-05-27 アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ[1,5−a]ピリジン誘導体

Country Status (10)

Country Link
US (2) US20080076784A1 (enExample)
EP (2) EP1749005A1 (enExample)
JP (2) JP5179174B2 (enExample)
CN (2) CN1960991A (enExample)
AR (2) AR049125A1 (enExample)
BR (2) BRPI0510409A (enExample)
CA (2) CA2568159A1 (enExample)
IL (2) IL179408A0 (enExample)
TW (2) TW200612947A (enExample)
WO (2) WO2005118581A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080076784A1 (en) 2004-05-28 2008-03-27 Peter Herold Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors
AR049667A1 (es) * 2004-07-09 2006-08-23 Speedel Experimenta Ag Heterociclos condensados conteniendo n como inhibidores de aromatasa y procedimiento para prepararlos
TW200804378A (en) * 2005-12-09 2008-01-16 Speedel Experimenta Ag Organic compounds
TW200804284A (en) * 2006-03-31 2008-01-16 Speedel Experimenta Ag Process for preparing 6,7-dihydro-5H-imidazo[1,5-a]pyridin-8-one
EP1842543A1 (en) 2006-04-05 2007-10-10 Speedel Pharma AG Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
TW200813071A (en) 2006-04-12 2008-03-16 Speedel Experimenta Ag Spiro-imidazo compounds
TW200808813A (en) * 2006-04-12 2008-02-16 Speedel Experimenta Ag Imidazo compounds
TW200808812A (en) 2006-04-12 2008-02-16 Speedel Experimenta Ag Imidazo compounds
BRPI0916355B8 (pt) * 2008-07-24 2022-12-13 Meiji Seika Kaisha Vetor recombinante compreendendo um polinucleotídeo isolado, e, método para produzir um precursor de piripiropeno a
GB2477256B (en) * 2008-11-07 2013-12-25 Univ Sheffield Determination of predisposition towards subclinical Cushing's syndrome or incidentaloma
PL2426124T3 (pl) 2009-05-13 2013-12-31 Meiji Seika Pharma Co Ltd Sposób wytwarzania pirypiropenowych pochodnych
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
JP5420761B2 (ja) 2009-05-28 2014-02-19 ノバルティス アーゲー ネプリリシン阻害剤としての置換アミノプロピオン酸誘導体
ES2663351T3 (es) * 2009-11-17 2018-04-12 Novartis Ag Derivados de aril-piridina como inhibidores de la aldosterona sintasa
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
UA111151C2 (uk) 2010-03-01 2016-04-11 Мейдзі Сейка Фарма Ко., Лтд. Спосіб одержання похідних пірипіропену
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
PL2729142T3 (pl) 2011-07-08 2018-10-31 Novartis Ag Sposób leczenia miażdżycy tętnic u osobników z wysokim poziomem triglicerydów
CN103958478B (zh) * 2011-11-30 2017-08-01 霍夫曼-拉罗奇有限公司 双环二氢异喹啉‑1‑酮衍生物
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
NZ710574A (en) 2013-02-14 2017-11-24 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
US9266925B2 (en) 2013-07-25 2016-02-23 Novartis Ag Cyclic polypeptides for the treatment of heart failure
BR112016001376A2 (pt) 2013-07-25 2017-10-24 Novartis Ag bioconjugados de polipeptídeos de apelin sintéticos
CN105593212B (zh) * 2013-10-17 2019-06-04 豪夫迈·罗氏有限公司 作为醛固酮合酶抑制剂的苯基-二氢吡啶衍生物
JP6484616B2 (ja) * 2013-10-17 2019-03-13 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft アルドステロン合成酵素の阻害剤としてのフェニル−ジヒドロピリジン誘導体
MX2016003926A (es) * 2013-10-17 2016-06-17 Hoffmann La Roche Nuevos derivados de fenil-dihidropiridina como inhibidores de aldosterona sintasa.
CA2972871A1 (en) 2015-01-23 2016-07-28 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
WO2018165649A1 (en) 2017-03-10 2018-09-13 Embera Neurotherapeutics, Inc. Pharmaceutical compositions and uses thereof
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
UY38485A (es) 2018-11-27 2020-06-30 Novartis Ag Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
CN113166101A (zh) 2018-11-27 2021-07-23 诺华股份有限公司 作为治疗代谢障碍的蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型(PCSK9)抑制剂的环状五聚体化合物
JP7657151B2 (ja) 2018-11-27 2025-04-04 ノバルティス アーゲー 代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン/ケキシン9型(pcsk9)阻害剤としての環状ペプチド
TW202333563A (zh) 2021-11-12 2023-09-01 瑞士商諾華公司 用於治療疾病或障礙之二胺基環戊基吡啶衍生物
AR127698A1 (es) 2021-11-23 2024-02-21 Novartis Ag Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno
US20240391941A1 (en) 2023-05-24 2024-11-28 Novartis Ag Naphthyridinone derivatives for the treatment of a disease or disorder
CN117659075B (zh) * 2023-12-18 2025-02-11 中国科学院兰州化学物理研究所 一种咪唑衍生型柱[5]芳烃手性填料的制备及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4889861A (en) * 1982-12-21 1989-12-26 Ciba-Geigy Corp. Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
JPH0670064B2 (ja) 1986-12-08 1994-09-07 三井石油化学工業株式会社 二環性イミダゾ−ル誘導体
GB8820730D0 (en) * 1988-09-02 1988-10-05 Erba Carlo Spa Substituted 5 6 7 8-tetrahydroimidazo/1.5-a/pyridines & process for their preparation
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
CA2127689A1 (en) * 1992-01-27 1993-08-05 Marcel A. C. Janssen Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
WO1997000257A1 (en) * 1995-06-14 1997-01-03 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
JPH0971586A (ja) * 1995-09-07 1997-03-18 Yamanouchi Pharmaceut Co Ltd 新規な二環性縮合イミダゾール誘導体
US6333335B1 (en) * 1999-07-23 2001-12-25 Merck & Co., Inc. Phenyl-protein transferase inhibitors
JP2001151696A (ja) * 1999-11-22 2001-06-05 Keiko Tanaka アクチニジンから造る腫瘍の増殖ならびに転移抑制酵素と異質なたんぱく細胞の除去剤
EP1334106B1 (en) * 2000-11-17 2006-05-24 Takeda Pharmaceutical Company Limited Imidazole derivatives, production method thereof and use thereof
CA2568165A1 (en) * 2004-05-28 2005-12-15 Speedel Experimenta Ag Heterocyclic compounds and their use as aldosterone synthase inhibitors
AR050251A1 (es) * 2004-05-28 2006-10-11 Speedel Experimenta Ag Compuestos heterociclicos con nitrogeno heteroatomico y composicion farmaceutica en base al compuesto
US20080076784A1 (en) * 2004-05-28 2008-03-27 Peter Herold Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors
TW200716634A (en) * 2005-05-31 2007-05-01 Speedel Experimenta Ag Heterocyclic spiro-compounds
TW200716105A (en) * 2005-05-31 2007-05-01 Speedel Experimenta Ag Imidazole compounds
TW200808813A (en) * 2006-04-12 2008-02-16 Speedel Experimenta Ag Imidazo compounds
TW200813071A (en) * 2006-04-12 2008-03-16 Speedel Experimenta Ag Spiro-imidazo compounds
TW200808812A (en) * 2006-04-12 2008-02-16 Speedel Experimenta Ag Imidazo compounds

Similar Documents

Publication Publication Date Title
JP2008501000A5 (enExample)
JP2016503793A5 (enExample)
JP2005053931A5 (enExample)
JP2010504908A5 (enExample)
JP2009536620A5 (enExample)
JP2011513410A5 (enExample)
JP2009535462A5 (enExample)
JP2010520851A5 (enExample)
JP2015535277A5 (enExample)
JP2011500550A5 (enExample)
JP2006524660A5 (enExample)
JP2010501534A5 (enExample)
JP2007517807A5 (enExample)
JP2015143283A5 (enExample)
JP2012140458A5 (enExample)
JP2006522035A5 (enExample)
JP2007522220A5 (enExample)
JP2014504646A5 (enExample)
EA201270275A1 (ru) Кристаллическое соединение пиридазина
JP2011518218A5 (enExample)
JP2013507423A5 (enExample)
JP2013502441A5 (enExample)
JP2014500861A5 (enExample)
JP2007523941A5 (enExample)
JP2005289914A5 (enExample)